Report Detail
Global Isosorbide Mononitrate Sustained-release Tablet Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032
- RnM4743899 |
- 28 September, 2026 |
- Global |
- 104 Pages |
- GIR |
- Pharma & Healthcare
According to our (Global Info Research) latest study, the global Isosorbide Mononitrate Sustained-release Tablet market size was valued at US$ million in 2025 and is forecast to a readjusted size of US$ million by 2032 with a CAGR of %during review period.
Isosorbide mononitrate sustained-release tablets are a formulation of the medication used to prevent and relieve chest pain (angina) in individuals with coronary artery disease. These tablets are designed to provide a slow and controlled release of the medication, allowing for once-daily dosing in most cases.
The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.
This report is a detailed and comprehensive analysis for global Isosorbide Mononitrate Sustained-release Tablet market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2025, are provided.
Key Features:
Global Isosorbide Mononitrate Sustained-release Tablet market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Isosorbide Mononitrate Sustained-release Tablet market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Isosorbide Mononitrate Sustained-release Tablet market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2021-2032
Global Isosorbide Mononitrate Sustained-release Tablet market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2021-2026
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Isosorbide Mononitrate Sustained-release Tablet
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Isosorbide Mononitrate Sustained-release Tablet market based on the following parameters - company overview, sales quantity, revenue, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Mayo Clinic, Lotus Pharmaceuticals, Recipeharm, Hefei Cosource Pharmacetical, Lukang Jituan Saite Yaoye, Lepu Pharmaceuticals, Keyuan Pharmaceutical, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals.
Market Segmentation
Isosorbide Mononitrate Sustained-release Tablet market is split by Type and by Application. For the period 2021-2032, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
40mg
50mg
Other
Market segment by Application
Hospital
Clinic
Other
Major players covered
Mayo Clinic
Lotus Pharmaceuticals
Recipeharm
Hefei Cosource Pharmacetical
Lukang Jituan Saite Yaoye
Lepu Pharmaceuticals
Keyuan Pharmaceutical
Market segment by region, regional analysis covers
North America (United States, Canada, and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Isosorbide Mononitrate Sustained-release Tablet product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Isosorbide Mononitrate Sustained-release Tablet, with price, sales quantity, revenue, and global market share of Isosorbide Mononitrate Sustained-release Tablet from 2021 to 2026.
Chapter 3, the Isosorbide Mononitrate Sustained-release Tablet competitive situation, sales quantity, revenue, and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Isosorbide Mononitrate Sustained-release Tablet breakdown data are shown at the regional level, to show the sales quantity, consumption value, and growth by regions, from 2021 to 2032.
Chapter 5 and 6, to segment the sales by Type and by Application, with sales market share and growth rate by Type, by Application, from 2021 to 2032.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value, and market share for key countries in the world, from 2021 to 2026.and Isosorbide Mononitrate Sustained-release Tablet market forecast, by regions, by Type, and by Application, with sales and revenue, from 2027 to 2032.
Chapter 12, market dynamics, drivers, restraints, trends, and Porters Five Forces analysis.
Chapter 13, the key raw materials and key suppliers, and industry chain of Isosorbide Mononitrate Sustained-release Tablet.
Chapter 14 and 15, to describe Isosorbide Mononitrate Sustained-release Tablet sales channel, distributors, customers, research findings and conclusion.
1 Market Overview
- 1.1 Product Overview and Scope
- 1.2 Market Estimation Caveats and Base Year
- 1.3 Market Analysis by Type
- 1.3.1 Overview: Global Isosorbide Mononitrate Sustained-release Tablet Consumption Value by Type: 2021 Versus 2025 Versus 2032
- 1.3.2 40mg
- 1.3.3 50mg
- 1.3.4 Other
- 1.4 Market Analysis by Application
- 1.4.1 Overview: Global Isosorbide Mononitrate Sustained-release Tablet Consumption Value by Application: 2021 Versus 2025 Versus 2032
- 1.4.2 Hospital
- 1.4.3 Clinic
- 1.4.4 Other
- 1.5 Global Isosorbide Mononitrate Sustained-release Tablet Market Size & Forecast
- 1.5.1 Global Isosorbide Mononitrate Sustained-release Tablet Consumption Value (2021 & 2025 & 2032)
- 1.5.2 Global Isosorbide Mononitrate Sustained-release Tablet Sales Quantity (2021-2032)
- 1.5.3 Global Isosorbide Mononitrate Sustained-release Tablet Average Price (2021-2032)
2 Manufacturers Profiles
- 2.1 Mayo Clinic
- 2.1.1 Mayo Clinic Details
- 2.1.2 Mayo Clinic Major Business
- 2.1.3 Mayo Clinic Isosorbide Mononitrate Sustained-release Tablet Product and Services
- 2.1.4 Mayo Clinic Isosorbide Mononitrate Sustained-release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.1.5 Mayo Clinic Recent Developments/Updates
- 2.2 Lotus Pharmaceuticals
- 2.2.1 Lotus Pharmaceuticals Details
- 2.2.2 Lotus Pharmaceuticals Major Business
- 2.2.3 Lotus Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Product and Services
- 2.2.4 Lotus Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.2.5 Lotus Pharmaceuticals Recent Developments/Updates
- 2.3 Recipeharm
- 2.3.1 Recipeharm Details
- 2.3.2 Recipeharm Major Business
- 2.3.3 Recipeharm Isosorbide Mononitrate Sustained-release Tablet Product and Services
- 2.3.4 Recipeharm Isosorbide Mononitrate Sustained-release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.3.5 Recipeharm Recent Developments/Updates
- 2.4 Hefei Cosource Pharmacetical
- 2.4.1 Hefei Cosource Pharmacetical Details
- 2.4.2 Hefei Cosource Pharmacetical Major Business
- 2.4.3 Hefei Cosource Pharmacetical Isosorbide Mononitrate Sustained-release Tablet Product and Services
- 2.4.4 Hefei Cosource Pharmacetical Isosorbide Mononitrate Sustained-release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.4.5 Hefei Cosource Pharmacetical Recent Developments/Updates
- 2.5 Lukang Jituan Saite Yaoye
- 2.5.1 Lukang Jituan Saite Yaoye Details
- 2.5.2 Lukang Jituan Saite Yaoye Major Business
- 2.5.3 Lukang Jituan Saite Yaoye Isosorbide Mononitrate Sustained-release Tablet Product and Services
- 2.5.4 Lukang Jituan Saite Yaoye Isosorbide Mononitrate Sustained-release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.5.5 Lukang Jituan Saite Yaoye Recent Developments/Updates
- 2.6 Lepu Pharmaceuticals
- 2.6.1 Lepu Pharmaceuticals Details
- 2.6.2 Lepu Pharmaceuticals Major Business
- 2.6.3 Lepu Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Product and Services
- 2.6.4 Lepu Pharmaceuticals Isosorbide Mononitrate Sustained-release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.6.5 Lepu Pharmaceuticals Recent Developments/Updates
- 2.7 Keyuan Pharmaceutical
- 2.7.1 Keyuan Pharmaceutical Details
- 2.7.2 Keyuan Pharmaceutical Major Business
- 2.7.3 Keyuan Pharmaceutical Isosorbide Mononitrate Sustained-release Tablet Product and Services
- 2.7.4 Keyuan Pharmaceutical Isosorbide Mononitrate Sustained-release Tablet Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2021-2026)
- 2.7.5 Keyuan Pharmaceutical Recent Developments/Updates
3 Competitive Environment: Isosorbide Mononitrate Sustained-release Tablet by Manufacturer
- 3.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales Quantity by Manufacturer (2021-2026)
- 3.2 Global Isosorbide Mononitrate Sustained-release Tablet Revenue by Manufacturer (2021-2026)
- 3.3 Global Isosorbide Mononitrate Sustained-release Tablet Average Price by Manufacturer (2021-2026)
- 3.4 Market Share Analysis (2025)
- 3.4.1 Producer Shipments of Isosorbide Mononitrate Sustained-release Tablet by Manufacturer Revenue ($MM) and Market Share (%): 2025
- 3.4.2 Top 3 Isosorbide Mononitrate Sustained-release Tablet Manufacturer Market Share in 2025
- 3.4.3 Top 6 Isosorbide Mononitrate Sustained-release Tablet Manufacturer Market Share in 2025
- 3.5 Isosorbide Mononitrate Sustained-release Tablet Market: Overall Company Footprint Analysis
- 3.5.1 Isosorbide Mononitrate Sustained-release Tablet Market: Region Footprint
- 3.5.2 Isosorbide Mononitrate Sustained-release Tablet Market: Company Product Type Footprint
- 3.5.3 Isosorbide Mononitrate Sustained-release Tablet Market: Company Product Application Footprint
- 3.6 New Market Entrants and Barriers to Market Entry
- 3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
- 4.1 Global Isosorbide Mononitrate Sustained-release Tablet Market Size by Region
- 4.1.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales Quantity by Region (2021-2032)
- 4.1.2 Global Isosorbide Mononitrate Sustained-release Tablet Consumption Value by Region (2021-2032)
- 4.1.3 Global Isosorbide Mononitrate Sustained-release Tablet Average Price by Region (2021-2032)
- 4.2 North America Isosorbide Mononitrate Sustained-release Tablet Consumption Value (2021-2032)
- 4.3 Europe Isosorbide Mononitrate Sustained-release Tablet Consumption Value (2021-2032)
- 4.4 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Consumption Value (2021-2032)
- 4.5 South America Isosorbide Mononitrate Sustained-release Tablet Consumption Value (2021-2032)
- 4.6 Middle East & Africa Isosorbide Mononitrate Sustained-release Tablet Consumption Value (2021-2032)
5 Market Segment by Type
- 5.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales Quantity by Type (2021-2032)
- 5.2 Global Isosorbide Mononitrate Sustained-release Tablet Consumption Value by Type (2021-2032)
- 5.3 Global Isosorbide Mononitrate Sustained-release Tablet Average Price by Type (2021-2032)
6 Market Segment by Application
- 6.1 Global Isosorbide Mononitrate Sustained-release Tablet Sales Quantity by Application (2021-2032)
- 6.2 Global Isosorbide Mononitrate Sustained-release Tablet Consumption Value by Application (2021-2032)
- 6.3 Global Isosorbide Mononitrate Sustained-release Tablet Average Price by Application (2021-2032)
7 North America
- 7.1 North America Isosorbide Mononitrate Sustained-release Tablet Sales Quantity by Type (2021-2032)
- 7.2 North America Isosorbide Mononitrate Sustained-release Tablet Sales Quantity by Application (2021-2032)
- 7.3 North America Isosorbide Mononitrate Sustained-release Tablet Market Size by Country
- 7.3.1 North America Isosorbide Mononitrate Sustained-release Tablet Sales Quantity by Country (2021-2032)
- 7.3.2 North America Isosorbide Mononitrate Sustained-release Tablet Consumption Value by Country (2021-2032)
- 7.3.3 United States Market Size and Forecast (2021-2032)
- 7.3.4 Canada Market Size and Forecast (2021-2032)
- 7.3.5 Mexico Market Size and Forecast (2021-2032)
8 Europe
- 8.1 Europe Isosorbide Mononitrate Sustained-release Tablet Sales Quantity by Type (2021-2032)
- 8.2 Europe Isosorbide Mononitrate Sustained-release Tablet Sales Quantity by Application (2021-2032)
- 8.3 Europe Isosorbide Mononitrate Sustained-release Tablet Market Size by Country
- 8.3.1 Europe Isosorbide Mononitrate Sustained-release Tablet Sales Quantity by Country (2021-2032)
- 8.3.2 Europe Isosorbide Mononitrate Sustained-release Tablet Consumption Value by Country (2021-2032)
- 8.3.3 Germany Market Size and Forecast (2021-2032)
- 8.3.4 France Market Size and Forecast (2021-2032)
- 8.3.5 United Kingdom Market Size and Forecast (2021-2032)
- 8.3.6 Russia Market Size and Forecast (2021-2032)
- 8.3.7 Italy Market Size and Forecast (2021-2032)
9 Asia-Pacific
- 9.1 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Sales Quantity by Type (2021-2032)
- 9.2 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Sales Quantity by Application (2021-2032)
- 9.3 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Market Size by Region
- 9.3.1 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Sales Quantity by Region (2021-2032)
- 9.3.2 Asia-Pacific Isosorbide Mononitrate Sustained-release Tablet Consumption Value by Region (2021-2032)
- 9.3.3 China Market Size and Forecast (2021-2032)
- 9.3.4 Japan Market Size and Forecast (2021-2032)
- 9.3.5 South Korea Market Size and Forecast (2021-2032)
- 9.3.6 India Market Size and Forecast (2021-2032)
- 9.3.7 Southeast Asia Market Size and Forecast (2021-2032)
- 9.3.8 Australia Market Size and Forecast (2021-2032)
10 South America
- 10.1 South America Isosorbide Mononitrate Sustained-release Tablet Sales Quantity by Type (2021-2032)
- 10.2 South America Isosorbide Mononitrate Sustained-release Tablet Sales Quantity by Application (2021-2032)
- 10.3 South America Isosorbide Mononitrate Sustained-release Tablet Market Size by Country
- 10.3.1 South America Isosorbide Mononitrate Sustained-release Tablet Sales Quantity by Country (2021-2032)
- 10.3.2 South America Isosorbide Mononitrate Sustained-release Tablet Consumption Value by Country (2021-2032)
- 10.3.3 Brazil Market Size and Forecast (2021-2032)
- 10.3.4 Argentina Market Size and Forecast (2021-2032)
11 Middle East & Africa
- 11.1 Middle East & Africa Isosorbide Mononitrate Sustained-release Tablet Sales Quantity by Type (2021-2032)
- 11.2 Middle East & Africa Isosorbide Mononitrate Sustained-release Tablet Sales Quantity by Application (2021-2032)
- 11.3 Middle East & Africa Isosorbide Mononitrate Sustained-release Tablet Market Size by Country
- 11.3.1 Middle East & Africa Isosorbide Mononitrate Sustained-release Tablet Sales Quantity by Country (2021-2032)
- 11.3.2 Middle East & Africa Isosorbide Mononitrate Sustained-release Tablet Consumption Value by Country (2021-2032)
- 11.3.3 Turkey Market Size and Forecast (2021-2032)
- 11.3.4 Egypt Market Size and Forecast (2021-2032)
- 11.3.5 Saudi Arabia Market Size and Forecast (2021-2032)
- 11.3.6 South Africa Market Size and Forecast (2021-2032)
12 Market Dynamics
- 12.1 Isosorbide Mononitrate Sustained-release Tablet Market Drivers
- 12.2 Isosorbide Mononitrate Sustained-release Tablet Market Restraints
- 12.3 Isosorbide Mononitrate Sustained-release Tablet Trends Analysis
- 12.4 Porters Five Forces Analysis
- 12.4.1 Threat of New Entrants
- 12.4.2 Bargaining Power of Suppliers
- 12.4.3 Bargaining Power of Buyers
- 12.4.4 Threat of Substitutes
- 12.4.5 Competitive Rivalry
13 Raw Material and Industry Chain
- 13.1 Raw Material of Isosorbide Mononitrate Sustained-release Tablet and Key Manufacturers
- 13.2 Manufacturing Costs Percentage of Isosorbide Mononitrate Sustained-release Tablet
- 13.3 Isosorbide Mononitrate Sustained-release Tablet Production Process
- 13.4 Industry Value Chain Analysis
14 Shipments by Distribution Channel
- 14.1 Sales Channel
- 14.1.1 Direct to End-User
- 14.1.2 Distributors
- 14.2 Isosorbide Mononitrate Sustained-release Tablet Typical Distributors
- 14.3 Isosorbide Mononitrate Sustained-release Tablet Typical Customers
15 Research Findings and Conclusion
16 Appendix
- 16.1 Methodology
- 16.2 Research Process and Data Source
Summary:
Get latest Market Research Reports on Isosorbide Mononitrate Sustained-release Tablet. Industry analysis & Market Report on Isosorbide Mononitrate Sustained-release Tablet is a syndicated market report, published as Global Isosorbide Mononitrate Sustained-release Tablet Market 2026 by Manufacturers, Regions, Type and Application, Forecast to 2032. It is complete Research Study and Industry Analysis of Isosorbide Mononitrate Sustained-release Tablet market, to understand, Market Demand, Growth, trends analysis and Factor Influencing market.
REPORT YOU MIGHT BE INTERESTED
Related Reports
Reason to Buy
Reports and Markets
Contact Us
+1-352-353-0818 (US)Newsletter
KEEP UP TO DATE ON ALL THE LATEST REPORTS
